Shukra Pharmaceuticals standalone net profit rises 35.09% in the March 2025 quarter

Net profit of Shukra Pharmaceuticals rose 35.09% to Rs 5.39 crore in the quarter ended March 2025 as against Rs 3.99 crore during the previous quarter ended March 2024. Sales rose 21.97% to Rs 13.27 crore in the quarter ended March 2025 as against Rs 10.88 crore during the previous quarter ended March 2024.

For the full year,net profit declined 48.33% to Rs 9.58 crore in the year ended March 2025 as against Rs 18.54 crore during the previous year ended March 2024. Sales declined 56.30% to Rs 32.59 crore in the year ended March 2025 as against Rs 74.57 crore during the previous year ended March 2024.

Particulars	Quarter Ended			Year Ended
	Mar. 2025	Mar. 2024	% Var.	Mar. 2025	Mar. 2024	% Var.
Sales	13.27	10.88	22	32.59	74.57	-56
OPM %	55.09	40.81	-	39.03	26.02	-
PBDT	8.51	5.75	48	16.34	21.93	-25
PBT	7.57	5.23	45	13.34	19.88	-33
NP	5.39	3.99	35	9.58	18.54	-48